First Time Loading...
M

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993

Watchlist Manager
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Watchlist
Price: 27.84 CNY 2.5% Market Closed
Updated: May 4, 2024
Mayinglong Pharmaceutical Group Co Ltd
/
Income Statement
/
Interest Income Expense

Mayinglong Pharmaceutical Group Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayinglong Pharmaceutical Group Co Ltd
Interest Income Expense Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
M
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Interest Income Expense
¥128.3m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
17%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Interest Income Expense
¥82m
CAGR 3-Years
-36%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Interest Income Expense
¥132.8m
CAGR 3-Years
6%
CAGR 5-Years
30%
CAGR 10-Years
41%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Interest Income Expense
¥782m
CAGR 3-Years
11%
CAGR 5-Years
27%
CAGR 10-Years
48%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Interest Income Expense
¥1.1B
CAGR 3-Years
-26%
CAGR 5-Years
8%
CAGR 10-Years
42%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Interest Income Expense
¥103.6m
CAGR 3-Years
85%
CAGR 5-Years
83%
CAGR 10-Years
N/A

See Also

What is Mayinglong Pharmaceutical Group Co Ltd's Interest Income Expense?
Interest Income Expense
128.3m CNY

Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Interest Income Expense amounts to 128.3m CNY.

What is Mayinglong Pharmaceutical Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
17%

Over the last year, the Interest Income Expense growth was 102%. The average annual Interest Income Expense growth rates for Mayinglong Pharmaceutical Group Co Ltd have been 10% over the past three years , and 17% over the past ten years .

ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.